West Pharmaceutical Services, Inc. (WST)

Market Cap	26.03B
Revenue (ttm)	2.93B
Net Income (ttm)	559.40M
Shares Out	73.99M
EPS (ttm)	7.42
PE Ratio	47.41
Forward PE	41.80
Dividend	$0.80 (0.23%)
Ex-Dividend Date	Nov 7, 2023

Volume	267,920
Open	350.31
Previous Close	350.76
Day's Range	349.47 - 355.25
52-Week Range	224.15 - 415.73
Beta	1.08
Analysts	Buy
Price Target	347.00 (-1.36%)
Earnings Date	Oct 26, 2023

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,700
• Stock Exchange: NYSE
• Ticker Symbol: WST

Financial Performance

In 2022, WST's revenue was $2.89 billion, an increase of 1.95% compared to the previous year's $2.83 billion. Earnings were $585.90 million, a decrease of -11.47%.

Analyst Forecast

According to 5 analysts, the average rating for WST stock is "Buy." The 12-month stock price forecast is $347.0, which is a decrease of -1.36% from the latest price.

Price Target

$347.0

(-1.36% downside)

Analyst Consensus: Buy